MOST
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke.
The MOST study is designed to find out whether adding one of two blood thinning medicines to standard treatment helps decrease the impact of strokes and is safe.
Principal Investigator: Dr. Aniel Majjhoo
Contact: study coordinator
Phone (Main): 810-342-3067
IRB Number: 2019-05-006
Current Trial Type: NCT03735979